Prothena Corporation is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in the discovery, development, and commercialization of some of their novel antibodies.
The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.
“Our strategy is to apply our extensive expertise in generating novel therapeutic antibodies and work with collaborators having expertise in specific animal models of disease, to identify antibody candidates for clinical development.” (Page 3) Read the full document
Prothena Corp. Plc is a clinical stage biotechnology company, which engages in the discovery, development, and commercialization of novel antibodies. Its antibody-based product candidates target a number of potential indications including AL amyloidosis (NEOD001), Parkinson’s disease and related synucleinopathies (PRX002), inflammatory diseases including psoriasis, psoriatic arthritis (PRX003), and ATTR amyloidosis (PRX004).
Company Website: http://www.prothena.com